R1	Has_index Arg1:T18 Arg2:T19	
R2	Has_temporal Arg1:T17 Arg2:T18	
R3	Has_index Arg1:T21 Arg2:T22	
R4	Has_temporal Arg1:T20 Arg2:T21	
R5	Has_index Arg1:T26 Arg2:T27	
R6	Has_temporal Arg1:T25 Arg2:T26	
R7	Has_temporal Arg1:T24 Arg2:T26	
R8	Has_qualifier Arg1:T32 Arg2:T34	
R9	Has_qualifier Arg1:T33 Arg2:T34	
*	OR T32 T33
R10	Has_temporal Arg1:T32 Arg2:T31	
*	OR T37 T38
R11	Has_temporal Arg1:T38 Arg2:T39	
R12	Has_temporal Arg1:T37 Arg2:T39	
R13	Has_value Arg1:T41 Arg2:T45	
*	OR T41 T42 T43
R14	Has_value Arg1:T55 Arg2:T56	
R15	Has_value Arg1:T54 Arg2:T53	
*	OR T54 T55
R16	AND Arg1:T52 Arg2:T54	
*	OR T52 T57
*	OR T50 T51
R17	Subsumes Arg1:T50 Arg2:T52	
R18	AND Arg1:T77 Arg2:T76	
R19	AND Arg1:T78 Arg2:T76	
*	OR T78 T77
R20	Has_temporal Arg1:T79 Arg2:T81	
*	OR T79 T82
R21	Has_qualifier Arg1:T82 Arg2:T83	
T1	Parsing_Error 0 2	1.
T2	Non-query-able 3 47	Institutionalized subjects will not be used.
T3	Parsing_Error 66 68	1.
T4	Parsing_Error 48 64	2 Social Habits:
T5	Drug 80 96	tobacco products
T6	Not_a_criteria 102 246	Ingestion of any alcoholic, caffeine- or xanthine-containing food or beverage within the 48 hours prior to the initial dose of study medication.
T7	Parsing_Error 99 101	2.
T8	Not_a_criteria 251 366	Ingestion of any vitamins or herbal products within the 48 hours prior to the initial dose of the study medication.
T9	Non-query-able 371 432	Any recent, significant change in dietary or exercise habits.
T10	Context_Error 437 498	Positive test for any drug included in the urine drug screen.
T11	Parsing_Error 248 250	3.
T12	Parsing_Error 368 370	4.
T13	Parsing_Error 434 436	5.
T14	Parsing_Error 500 502	3.
T15	Parsing_Error 517 519	1.
T16	Parsing_Error 609 611	2.
T17	Drug 531 541	medication
T18	Temporal 542 566	within the 14 days prior
T19	Reference_point 570 606	the initial dose of study medication
T20	Drug 623 672	medication known to alter hepatic enzyme activity
T21	Temporal 673 693	within 28 days prior
T22	Reference_point 697 733	the initial dose of study medication
T23	Parsing_Error 736 738	3.
T24	Drug 746 769	hormonal contraceptives
T25	Drug 774 802	hormonal replacement therapy
T26	Temporal 803 828	within three months prior
T27	Reference_point 832 868	the initial dose of study medication
T28	Parsing_Error 871 873	4.
T29	Parsing_Error 874 883	Diseases:
T30	Parsing_Error 885 887	a.
T31	Temporal 888 895	History
T32	Condition 915 930	chronic disease
T33	Condition 938 947	hepatitis
T34	Qualifier 903 914	significant
T35	Subjective_judgement 903 914	significant
T37	Condition 963 967;983 988	drug abuse
T38	Condition 975 988	alcohol abuse
T39	Temporal 952 959	History
T40	Undefined_semantics 993 1071	Acute illness at the time of either the prestudy medical evaluation or dosing.
T41	Measurement 1085 1088;1118 1122	HIV test
T42	Measurement 1090 1101;1118 1122	Hepatitis B test
T43	Measurement 1106 1122	Hepatitis C test
T45	Value 1076 1084	Positive
T46	Parsing_Error 949 951	b.
T47	Parsing_Error 990 992	c.
T48	Parsing_Error 1073 1075	d.
T49	Parsing_Error 1124 1126	e.
T50	Condition 1127 1140	Renal disease
T51	Condition 1144 1161	renal dysfunction
T52	Measurement 1179 1202	serum creatinine levels
T53	Value 1203 1237	greater than or equal to 1.5 mg/dL
T54	Person 1243 1248	males
T55	Person 1294 1301	females
T56	Value 1254 1288	greater than or equal to 1.4 mg/dL
T57	Condition 1306 1335	abnormal creatinine clearance
T61	Parsing_Error 1339 1341	5.
T62	Parsing_Error 1342 1402	Abnormal and clinically significant laboratory test results:
T63	Parsing_Error 1404 1406	1.
T64	Subjective_judgement 1342 1402	Abnormal and clinically significant laboratory test results:
T65	Subjective_judgement 1407 1429	Clinically significant
T66	Context_Error 1449 1492	Guide for Clinically Relevant Abnormalities
T67	Non-query-able 1407 1557	Clinically significant deviation from the Guide for Clinically Relevant Abnormalities (see Part II ADMINISTRATIVE ASPECTS OF BIOEQUIVALENCE PROTOCOLS)
T68	Parsing_Error 1560 1562	2.
T69	Condition 1563 1571;1596 1607	Abnormal ECG tracing
T70	Subjective_judgement 1576 1595	clinically relevant
T71	Parsing_Error 1609 1611	6.
T72	Non-query-able 1612 1744	Donation or loss of a significant volume of blood or plasma (> 450 mL) within 28 days prior to the initial dose of study medication.
T73	Parsing_Error 1746 1748	7.
T74	Non-query-able 1749 1861	Subjects who have received an investigational drug within 30 days prior to the initial dose of study medication.
T75	Parsing_Error 1863 1865	8.
T76	Drug 1897 1920	metformin hydrochloride
T77	Condition 1877 1893	hypersensitivity
T78	Condition 1866 1873	Allergy
T80	Parsing_Error 1922 1924	9.
T79	Condition 1936 1971	difficulty in swallowing medication
T81	Temporal 1925 1932	History
T82	Condition 1980 2005	gastrointestinal disorder
T83	Qualifier 2018 2044	affect the drug absorption
T84	Subjective_judgement 2018 2044	affect the drug absorption
